Generation of a new chimeric antigen receptor (CAR) to target CD23 expressed on B-chronic lymphocytic leukemia (B-CLL) cells

被引：0
|
作者：
Attianese, Greta Maria Paola Giordano [1 ]
Hoyos, Vera [2 ]
Savoldo, Barbara [2 ]
Marin, Virna [1 ]
Brandi, Malika [1 ]
Biondi, Andrea [1 ]
Biagi, Ettore [1 ]
Dotti, GianPietro [2 ]
机构：
[1] Univ Milano Bicocca, Dept Pediat, M Tettamanti Res Ctr, Monza, Italy
[2] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
来源：
HUMAN GENE THERAPY | 2008年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
下载
收藏
页码：1136 / 1136
页数：1
相关论文
共 50 条
  • [21] UCN-01 chemosensitizes human B-chronic lymphocytic leukemia (B-CLL) cells to the effects of fludarabine.
    Willis, C
    Byrd, JC
    Shinn, C
    Flinn, IW
    Grever, MR
    BLOOD, 1999, 94 (10) : 127A - 127A
  • [22] Perforin and serine esterase-expressing circulating CD4+cells are present in patients with B-chronic lymphocytic leukemia (B-CLL).
    Porakishvili, N
    Roschupkina, T
    Jewell, AP
    Patterson, K
    Yong, K
    Lydyard, PM
    BLOOD, 1999, 94 (10) : 437A - 437A
  • [23] PHENOTYPIC, CYTOGENETIC AND MOLECULAR CHARACTERIZATION OF A NEW B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) CELL-LINE
    CALIGARISCAPPIO, F
    BERGUI, L
    REGECAMBRIN, G
    TESIO, L
    MIGONE, N
    MALAVASI, F
    LEUKEMIA RESEARCH, 1987, 11 (07) : 579 - &
  • [24] FLUDARABINE AND PREDNISONE IN PRETREATED AND REFRACTORY B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) IN ADVANCED STAGES
    DEROSSI, G
    MAURO, FR
    CARUSO, R
    MONARCA, B
    MANDELLI, F
    HAEMATOLOGICA, 1993, 78 (03) : 167 - 171
  • [25] Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL)
    Porakishvili, N
    Roschupkina, T
    Kalber, T
    Jewell, AP
    Patterson, K
    Yong, K
    Lydyard, PM
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 126 (01): : 29 - 36
  • [26] Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters
    Vladimir Jurisic
    Natasa Colovic
    Nada Kraguljac
    Henry Dushan Atkinson
    Milica Colovic
    Medical Oncology, 2008, 25 : 315 - 322
  • [27] Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters
    Jurisic, Vladimir
    Colovic, Natasa
    Kraguljac, Nada
    Atkinson, Henry Dushan
    Colovic, Milica
    MEDICAL ONCOLOGY, 2008, 25 (03) : 315 - 322
  • [28] PHENOTYPE OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) B-CELLS - B-CLL CELLS EXPRESS THE LEU-8 ANTIGEN
    CAFARO, A
    NAPOLITANO, M
    ZOLI, V
    PACILLI, L
    MEZZAROMA, I
    DELAURENZI, A
    PANDOLFI, F
    BLUT, 1987, 54 (01): : 43 - 49
  • [29] THE ORIGIN OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) AND ITS RELATIONSHIP TO HAIRY-CELL LEUKEMIA (HCL)
    CALIGARISCAPPIO, F
    BERGUI, L
    PIZZOLO, G
    CHILOSI, M
    TESIO, L
    CAMPANA, D
    SEMENZATO, G
    MALAVASI, F
    GOBBI, M
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1985, 186 : 949 - 956
  • [30] COMBINING CD23 CHIMERIC ANTIGEN RECEPTOR IMMUNOTHERAPY AND LENALIDOMIDE AS A NOVEL THERAPEUTIC STRATEGY FOR CHRONIC LYMPHOCYTIC LEUKEMIA
    Bertilaccio, M.
    Tettamanti, S.
    Attianese, G. G.
    Galletti, G.
    Arcangeli, S.
    Rodriguez, T.
    Magnani, C.
    Barbaglio, F.
    Scarfo, L.
    Ponzoni, M.
    Biondi, A.
    Caligaris-Cappio, F.
    Ghia, P.
    Biagi, E.
    CYTOTHERAPY, 2014, 16 (04) : S35 - S35
12345